DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
This review presents our own and literature data dedicated to predisposing and pathogenetic factors involved in development of a common comorbidity, diabetes-associated osteoarthritis (DAOA). So far, there is no wide-accepted clinical or scientific viewing of DAOA as a distinct clinical phenotype of...
Enregistré dans:
Auteurs principaux: | E. V. Kazygasheva, V. S. Shirinsky, I. V. Shirinsky |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7c891acefd2f44a092f26d0461ef567c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
par: I. V. Shirinsky, et autres
Publié: (2015) -
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
par: V. S. Shirinsky, et autres
Publié: (2017) -
COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
par: I. V. Shirinsky, et autres
Publié: (2015) -
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
par: I. V. Shirinsky, et autres
Publié: (2016) -
INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
par: V. S. Shirinsky, et autres
Publié: (2019)